Curevo Inc
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older (NCT05304351) | Curevo Inc | 2022-02-02 |
| Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects (NCT03820414) | Curevo Inc | 2019-01-03 |
Track Curevo Inc automatically
Every clearance here is in the API, with alerts when new ones post.